@surf4children Recover and relapse will be cyclical. The spike protein from SARS2 is the trigger. Allow it to remain the body and relapse is guaranteed.
@1goodtern Keep your nose clean. Covid starts there. Many publications on this. Key formulations in certain sprays address the complex challenge of CoV2.
@stkirsch SARS-CoV-2 is spike. The virus spike = the vaccine spike. And it's a long lasting problem that is slowly wreaking havoc on immune integrity across the board.
On Aug 14 2026 the CDC revised its thresholds on how Covid wastewater levels are visually categorized. What was once considered high is now moderate. What was moderate is now low.
Covid reinfection compounds risk of post-acute cognitive decline, fatigue, cardiovascular & respiratory complications and re-activation of latent viruses.
This is why clear wastewater reporting matters. Changing the colors on a dashboard doesn't change the underlying risk - only the recognition of it.
#DataTransparency
#LongCovid
#RiskManagement
https://t.co/duPY10wf7p
π¨BREAKING π¦
On Friday, the US CDC arbitrarily shifted higher COVlD levels into lower categories depicted with cooler colors.
Much of what was Very High is now "High." What was High is now "Moderate" or "Low." Low is "Very Low."
πΉ2 states/territories artificially shifted from High to Moderate (MS, GU)
πΉ5 shifted from Moderate to Low (CA, TX, AK, WA, NV)
πΉ4 shifted from Low to Very Low (AZ, AR, LA, NC)
During intense surges, states will rarely get classified as Very High anymore. Presently, transmission is rising across the US, with a 75% chance of a wave, but states will be depicted in blue (Very Low) much longer, making communities less prepared. #Bluewashing
Normally, when the CDC makes a methodology change, they flag it prominently on each of their COVlD monitoring pages. This time, there was no alert and no explanation. Major changes were confined to COVlD, not Influenza A, and not RSV. The questionable change was made in the middle of rising transmission across most of the country; 15 states already have COVlD outbreaks, and others may soon join the ranks. These are serious ethics concerns that warrant investigative journalism.
These issues are aggravated by delayed reporting at High/Very High monitoring sites. Sites with 1-week reporting delays get excluded when the CDC calculates current levels. For example, only 16% of the sites online in Texas (3 of 19) report High/Very High levels, but 90% of those with a 1-week reporting delay (18 of 20) have High/Very High levels, leading the state to get classified as "Low" when really High. These issues snowball and can easily push a state down 1-2 categories when experiencing significant COVlD outbreaks.
The good news is that the individual wastewater monitoring site data are still valid. The bad news is that the CDC maps and level descriptions will now mislead the casual user. Think: "Good data, bad use of data." At PMC, we told you that if there was any funny business at the CDC, we would warn you right away. We diagnosed the issue immediately and will still report accurate COVlD information.
Expect further national news coverage this week. Journalists are welcome to reach out.
When a platform is described as safe and effective, the delivery system deserves the same level of scrutiny as the active ingredient.
@stephanieseneff et al. argue that LNPs behave as a cell-stress switch promoting inflammation and contributing to broader dysfunction.
#Biotech
#LipidNanoparticles
#Pharma
#ResearchIntegrity
#SafeandEffective
#mRNA
https://t.co/d9JBhngdAa
For those that missed it, here is my last conversation with Dr Mary Talley Bowden, and our mutual patient Ken, who received treatment here in Tokyo, remission of malignant pericarditis, that was untreatable in the US.
https://t.co/0M1wefiSGS